Evidence map›Paper›PMID 39056768›Full record

ReviewCells2024

Advancements in Utilizing Natural Compounds for Modulating Autophagy in Liver Cancer: Molecular Mechanisms and Therapeutic Targets.

Md Ataur Rahman, S M Rakib-Uz-Zaman, Somdeepa Chakraborti, Sujay Kumar Bhajan, Rajat Das Gupta, Maroua Jalouli, Md Anowar Khasru Parvez, Mushfiq H Shaikh, Ehsanul Hoque Apu, Abdel Halim Harrath and 2 more

Abstract readReview
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Therapeutic potential of natural triterpenoids in liver cancer.Medical oncology (Northwood, London, England) · 2025
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Md Ataur RahmanDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0001-6649-3694
S M Rakib-Uz-ZamanDepartment of Biological Sciences, University of Delaware, Newark, DE 19716, USA.ORCID 0000-0003-4126-8751
Somdeepa ChakrabortiDepartment of Biological Sciences, University of Delaware, Newark, DE 19716, USA.ORCID 0009-0000-9553-7246
Sujay Kumar BhajanDepartment of Biotechnology & Genetic Engineering, Bangabandhu Sheikh Mujibur Rahman Science & Technology University, Gopalganj 8100, Bangladesh.ORCID 0009-0002-7564-2078
Rajat Das GuptaDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.ORCID 0000-0002-7680-676X
Maroua JalouliDepartment of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.ORCID 0000-0003-4726-0507
Md Anowar Khasru ParvezDepartment of Microbiology, Jahangirnagar University, Savar 1342, Bangladesh.ORCID 0000-0002-0246-3872
Mushfiq H ShaikhDepartment of Otolaryngology-Head & Neck Surgery, Western University, London, ON N6A 4V2, Canada.ORCID 0000-0001-9953-3939
Ehsanul Hoque ApuDepartment of Biomedical Sciences, College of Dental Medicine, Lincoln Memorial University, Knoxville, TN 37923, USA.ORCID 0000-0001-6840-3787
Abdel Halim HarrathZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-2170-1303
Seungjoon MoonDepartment of Pathology, College of Korean Medicine, Kyung Hee University, 1-5 Hoegidong Dongdaemun-gu, Seoul 02447, Republic of Korea.
Bonglee KimDepartment of Pathology, College of Korean Medicine, Kyung Hee University, 1-5 Hoegidong Dongdaemun-gu, Seoul 02447, Republic of Korea.ORCID 0000-0002-8678-156X

Funding

Chemistry-Biology Interface Predoctoral Training Grant 2024-2029T32GM133395 · NIGMS · UNIVERSITY OF DELAWARE · PI Catherine Leimkuhler Grimes · 2019 to 2026
$3.7M
Kyung Hee University KHU-20230914National Research Foundation of Korea NRF-2020R1I1A2066868NIGMS NIH HHS T32 GM133395
6 · The paper itself

Abstract

Autophagy, an intrinsic catabolic mechanism that eliminates misfolded proteins, dysfunctional organelles, and lipid droplets, plays a vital function in energy balance and cytoplasmic quality control, in addition to maintaining cellular homeostasis. Liver cancer such as hepatocellular carcinoma (HCC) is one of the most common causes of cancer deaths globally and shows resistance to several anticancer drugs. Despite the rising incidence and poor prognosis of malignant HCC, the underlying molecular mechanisms driving this aggressive cancer remain unclear. Several natural compounds, such as phytochemicals of dietary and non-dietary origin, affect hepatocarcinogenesis signaling pathways in vitro and in vivo, which may help prevent and treat HCC cells. Current HCC cells treatments include chemotherapy, radiation, and surgery. However, these standard therapies have substantial side effects, and combination therapy enhances side effects for an acceptable therapeutic benefit. Therefore, there is a need to develop treatment strategies for HCC cells that are more efficacious and have fewer adverse effects. Multiple genetic and epigenetic factors are responsible for the HCC cells to become resistant to standard treatment. Autophagy contributes to maintain cellular homeostasis, which activates autophagy for biosynthesis and mitochondrial regulation and recycling. Therefore, modifying autophagic signaling would present a promising opportunity to identify novel therapies to treat HCC cells resistant to current standard treatments. This comprehensive review illustrates how natural compounds demonstrate their anti-hepatocellular carcinoma function through autophagy.

Indexed as

AutophagyBiological ProductsLiver NeoplasmsAnimalsCarcinoma, HepatocellularHumansSignal TransductionBiological Productsautophagycancer therapyhepatocellular carcinomahomeostasisnatural compound

Identifiers

PMID39056768
PMCPMC11274515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.